A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Archive for category "AIMD Companies" (Page 8)
formats

St. Jude Warns Physicians of Potential Problem with QuickSite and QuickFlex LV CRT Leads

St. Jude announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite® and QuickFlex® Left-Ventricular Leads, used to connect Cardiac Resynchronization Therapy devices to the heart. The announcement noted that there have been no reports of patient injury or loss of therapy due to externalized conductors in

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Warns Physicians of Potential Problem with QuickSite and QuickFlex LV CRT Leads  comments 
formats

St. Jude Medical Announces Clinical Benefits of Quadripolar CRT Pacing at ACC

St. Jude Medical announced that clinical findings on quadripolar pacing will be presented at the 61st Annual Scientific Sessions of the American College of Cardiology (ACC, Chicago, March 24-27 2012). According to St. Jude’s announcement, quadripolar pacing allows physicians the ability to use multisite left-ventricular (LV) pacing.  Studies that examined the role of multisite pacing in improving hemodynamics and

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Medical Announces Clinical Benefits of Quadripolar CRT Pacing at ACC  comments 
formats

ImThera Receives CE Mark for the Aura6000 System to Treat Obstructive Sleep Apnea

  ImThera Medical announced this week that it received the CE Mark for the Aura6000 System to Treat Obstructive Sleep Apnea.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on ImThera Receives CE Mark for the Aura6000 System to Treat Obstructive Sleep Apnea  comments 
formats

Boston Scientific to Acquire Cameron Health for $150M Up-Front + $150M Upon FDA Approval

Boston Scientific announced the exercise of its option to acquire Cameron Health.  Cameron Health developed the world’s first and only commercially-available subcutaneous implantable cardioverter defibrillator – the S-ICD® System that I blogged about a few weeks ago. The agreement calls for an upfront payment of $150 million, payable upon transaction closing, an additional potential $150

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific to Acquire Cameron Health for $150M Up-Front + $150M Upon FDA Approval  comments 
formats

Medtronic Receives CE Mark for CapSure Sense MRI™ SureScan® Pacing Leads

Medtronic today announced the receipt of CE Mark and launch of the CapSure Sense MRI™ SureScan® pacing leads, which are approved for use during MRI procedures.  The newly approved leads are the smallest MR–Conditional leads available in the world with a 5.3 French isodiametric lead body.  The new leads are passive-fixation leads.  Previously approved Medtronic MR–Conditional leads

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
2 Comments  comments 
formats

The Australian Pacemaker: Telectronics (1965-1995)

In 1965, Australian medical device pioneer Noel Gray established Telectronics – Australia’s first manufacturing facility for producing pacemakers that were designed in-house.  Telectronics was an innovative developer, achieving some major successes in the early cardiac pacing field, for example, Telectronics’ leads allowed narrowing the pacing pulse to its current nominal of 0.5 milliseconds; encapsulating the pacemaker in titanium

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
3 Comments  comments 
formats

Micro Systems Technologies Offers Active Implantable Medical Device Development/Manufacturing Services

Micro Systems Technologies (MST) is the vertically-integrated supplier of microelectronics and implantable-grade components to Biotronik.  It now offers its development and manufacturing services to others. Through its companies, MST offers high-reliability microelectronic modules for implantable medical devices such as pacemakers, defibrillators, neurostimulators, and cochlear implants. MST can provide integrated solutions encompassing everything from conceptual design through high-volume

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Micro Systems Technologies Offers Active Implantable Medical Device Development/Manufacturing Services  comments 
formats

VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology

  On January 17, 2012, VeriTeQ Acquisition Corporation of Delray Beach, FL announced that it acquired the VeriChip implantable RFID technology and its related Health Link personal health record from PositiveID Corporation.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology  comments 
formats

DF-4 Connectors for Implantable Cardioverter Defibrillators Enter Use in the US

The DF-4 Connector was recently introduced by a joint group of CRM companies, physicians, and regulatory agencies as a way of easing the implant of ICDs by reducing defibrillation connections from three to one and by minimizing the number of set screws.  Prior to the development of the DF-4, traditional high-voltage connector systems required up to three connections.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on DF-4 Connectors for Implantable Cardioverter Defibrillators Enter Use in the US  comments 
formats

Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%

Today Boston Scientific Corporation announced financial results for the fourth quarter and full year ended December 31, 2011.  Summarizing the AIMD data: On a constant-currency basis, Q4 2011 CRM sales were $482M compared to $564M in Q4 2010, or  down 15% On a constant-currency basis, 2011 CRM sales were $2,087M compared to $2,180M in Q4 2010,

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%  comments 
formats

Remon Medical’s Implantable Pulmonary Pressure Sensor (1997-2007)

Remon Medical Technologies, Ltd. was founded in 1997 in Caesarea, Israel to develop implantable, wireless pressure sensors. Remon developed an implantable hemodynamic monitor, which allowed on-demand, non-invasive, leadless self-monitoring of pulmonary artery pressure by the patient at home. ImPressure devices were placed in the pulmonary artery, and transmitted pressure readings to a hand-held monitor.  It was hoped that the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 
formats

SMSI® Implantable Glucose Sensor

Sensors for Medicine and Science, Inc. (SMSI)  of Germantown, MD was founded in 1997 to develop chemical sensing technologies based on fluorescence sensing. SMSI® is now developing an implantable glucose sensor that is designed to automatically measure interstitial glucose every few minutes. The sensor implant communicates wirelessly with a small external reader, allowing it to track

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on SMSI® Implantable Glucose Sensor  comments 
formats

St. Jude Medical’s Active Implantable Sales for 2011: CRM Down 3%, Neuromodulation Up 8%

St. Jude Medical today reported sales and net earnings for the fourth quarter and year ended December 31, 2011.    From the press release: “Cardiac Rhythm Management Total CRM sales, which include implantable cardioverter defibrillator (ICD) and pacemaker products, were$728 million for the fourth quarter of 2011, a 4 percent decrease compared to the fourth quarter of 2010.   After

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Medical’s Active Implantable Sales for 2011: CRM Down 3%, Neuromodulation Up 8%  comments 
formats

Elema-Schoenander and the Very First Human Implants of a Pacemaker in Sweden (1958) and Uruguay (1960)

This is a picture of the first pacemaker to be implanted in a human patient.  It was developed by Dr. Rune Elmqvist (1906–1996), a physician by training, but working for the Swedish company Elema-Schonander as an engineer.   Dr. Elmqvist  developed the device in cooperation of Åke Senning, senior physician and cardiac surgeon at the Karolinska University Hospital in Solna, Sweden.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Elema-Schoenander and the Very First Human Implants of a Pacemaker in Sweden (1958) and Uruguay (1960)  comments 
formats

“Data Block” Percutaneous Implantable Electrical Connector

The development of medical devices, drugs, and treatments depends on accurately retrieving clinical data from implanted animals. Implantable data collecting and sensing devices provide one way to retrieve these data. These device often include sensors or electrodes which must be implanted within the subject in order to provide clinicians with access to the sensed information.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on “Data Block” Percutaneous Implantable Electrical Connector  comments